CSPC PHARMA (01093): CSPC Innovation Pharmaceutical (300765.SZ) reported a net profit attributable to shareholders of approximately 1.261 billion yuan in the first half of the year, turning losses into profits year-on-year.
Shiyao Group (01093) announced the mid-term performance of Shiyao Innovation (300765.SZ) for 2026, with operating revenue of approximately 3.24 billion yuan, a year-on-year increase of 208.72%; the net profit attributable to shareholders of the listed company was approximately 1.261 billion yuan, turning a loss into a profit year-on-year; basic earnings per share were 0.9056 yuan.
CSPC PHARMA (01093) announced that CSPC Innovation Pharmaceutical (300765.SZ) reported its mid-year performance for 2026, with operating revenue of approximately 3.24 billion yuan, a year-on-year increase of 208.72%; the net profit attributable to shareholders of the listed company was approximately 1.261 billion yuan, turning a profit from a loss compared to the previous year; basic earnings per share were 0.9056 yuan.
Related Articles
NT PHARMA (01011) has significant objections to the ruling and has engaged a compliance legal service team to initiate statutory procedures for the application to revoke the ruling.
.png)
US Stock Market Move | Apple Inc. (AAPL.US) rose nearly 2%, with the iPhone 17 series potentially increasing by almost a thousand yuan.
E-STATION GTECH (08475): Request for review of the decision by the Listing Committee to cancel the company's listing status.
NT PHARMA (01011) has significant objections to the ruling and has engaged a compliance legal service team to initiate statutory procedures for the application to revoke the ruling.
US Stock Market Move | Apple Inc. (AAPL.US) rose nearly 2%, with the iPhone 17 series potentially increasing by almost a thousand yuan.
E-STATION GTECH (08475): Request for review of the decision by the Listing Committee to cancel the company's listing status.
RECOMMEND
